Introduction: Pestilence, Plague, Bioterrorism

Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats

Volumn , Issue , 2005, Pages 2-13

  Torrence, Paul F ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

Americas Incursion; Aztecs; Biological warfare; Incas; Measles; Native Americans; Smallpox; Yellow fever

Indexed keywords

EID: 84890987149     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471716715.ch1     Document Type: Editorial

References (143)

1. Material in this introduction has drawn heavily upon the following resources.
2. Diamond, J. Guns, Germs and Steel: The Fates of Human Societies, W. W. Norton, New York, 1999.
3. Karlen, A. Man and Microbes: Disease and Plagues in History and Modern Times, Simon and Schuster, New York, 1995.
4. Oldstone, M. B. A. Viruses, Plagues and History, Oxford University Press, New York, 1998.
5. Garrett, L. The Coming Plague: Newly Emerging Diseases in a World Out of Balance, Penguin Books, New York, 1995.
6. Preston, R. The Hot Zone, Random House, New York, 1994.
7. Black, F. L. Infectious diseases in primitive societies. Science 1975, 187(4176), 515-518.
8. Zinsser, H. Rats, Lice, and History. Little, Brown, & Co., Boston, 1935.
9. Smith, G. A Plague on Us, Commonwealth Fund, New York, 1941.
10. McNeill, W. Plagues and Peoples, Doubleday, Garden City, NY, 1976.
11. Edward, P. Evolution of Infectious Disease, Oxford University Press, New York, 1994.
12. Panum, P. Observations Made During the Epidemic of Measles on the Faroe Islands in the Year 1846, American Public Health Association, New York, 1940.
13. Cockburn, A.; Cockburn, E. eds., Mummies, Disease, and Ancient Cultures, Cambridge University Press, Cambridge, 1983.
14. Dobyns, H. Their Number Became Thinned, University of Tennessee Press, Knoxville, 1983.
15. Verano, J.; Ubelaker, B. eds. Disease and Demography in the Americas, Smithsonian Institution Press, Washington, DC, 1992.
16. Ramenofsky, A. Vectors of Death, University of New Mexico Press, Albuquerque, 1987.
17. Thornton, R. American Indian Holocaust and Survival, University of Oklahoma Press, Norman, 1987.
18. Snow, D. Microchronology and demographic evidence relating to the size of the pre-Columbian North American Indian population. Science 1995, 268, 1601-1604.
19. Curtin, P. Death by Migration: Europe's Encounter with the Tropical World in the 19th Century, Cambridge University Press, Cambridge, 1989.
20. Hopkins, D. Princes and Peasants: Smallpox in History, University of Chicago Press, Chicago, 1983.
21. Drexler, M. Secret Agents: The Menace of Emerging Infections, Joseph Henry Press, Washington, DC, 2002.
22. Dixon, S.; McDonald, S.; Roberts, J. The impact of HIV and AIDS on Africa's economic development. BMJ 2002, 324(7331), 232-234.
23. Whiteside, A. Demography and economics of HIV/AIDS. Br. Med. Bull. 2001, 58, 73-88.
24. Piot, P.; Bartos, M.; Ghys, P. D.; Walker, N.; Schwartlander, B. The global impact of HIV/AIDS. Nature 2001, 410(6831), 968-973.
25. Gayle, H. D.; Hill, G. L. Global impact of human immunodeficiency virus and AIDS. Clin. Microbiol. Rev. 2001, 14(2), 327-335.
26. Tomori, O. Yellow fever in Africa: public health impact and prospects for control in the 21st century. Biomedica 2002, 22(2), 178-210.
27. Sharma, S. N.; Raina, V. K.; Kumar, A. Dengue/DHF: an emerging disease in India. J. Commun. Dis. 2000, 175-9.
28. Linhares, A. C.; Bresee, J. S. Rotavirus vaccines and vaccination in Latin America. Rev. Panam. Salud Publica 2000, 8(5), 305-331.
29. Petersen, L. R.; Roehrig, J. T. West Nile virus: a reemerging global pathogen. Emerging Infect. Dis. 2001, 7(4), 611-614.
30. Solomon, T. Exotic and emerging viral encephalitides. Curr. Opin. Neurol. 2003, 16(3), 411-418.
31. Goldrick, B. A. Ebola outbreak in southern Sudan: seven have died, but it's contained-for now. Am. J. Nurs. 2004, 104(7), 29.
32. Ridel, G. M.; Luis, I. R.; Teja, J. Emerging and reemerging diseases: a health problem in the Americas. Rev. Panam. Salud Publica 2004, 15(4), 285-287.
33. Williams, E. S.; Yuill, T.; Artois, M.; Fischer, J.; Haigh, S. A. Emerging infectious diseases in wildlife. Rev. Sci. Tech. 2002, 21(1), 139-157.
34. Di Giulio, D. B.; Eckburg, P. B. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 2004, (1), 15-25.
35. Mackenzie, J. S.; Field, H. E. Emerging encephalitogenic viruses: lyssaviruses and henipaviruses transmitted by frugivorous bats. Arch. Virol. Suppl. 2004, (18), 97-111.
36. Vijayanand, P.; Wilkins, E.; Woodhead, M. Severe acute respiratory syndrome (SARS): a review. Clin. Med. 2004, 4(2), 152-160.
37. Woolhouse, M. E. Population biology of emerging and re-emerging pathogens. Trends Microbiol. 2002, 10(10 Suppl), S3-7.
38. Peters, W. Novel and challenging infections of man. A brief overview. Parassitologia 2002, 44(1-2), 33-42.
39. Harvell, C. D.; Mitchell, C. E.; Ward, J. R.; Altizer, S.; Dobson, A. P.; Ostfeld, R. S.; Samuel, M. D. Climate warming and disease risks for terrestrial and marine biota. Science 2002, 296(5576), 2158-2162.
40. Lee, L. M.; Henderson, D. K. Emerging viral infections. Curr. Opin. Infect. Dis. 2001, 14(4), 467-480.
41. Bengis, R. G.; Kock, R. A.; Fischer, J. Infectious animal diseases: the wildlife/livestock interface. Rev. Sci. Tech. 2002, 21(1), 53-65.
42. Kombe, G. C.; Darrow, D. M. Revisiting emerging infectious diseases: the unfinished agenda. J. Community Health 2001, 26(2), 113-122.
43. Daszak, P.; Cunningham, A. A.; Hyatt, A. D. Anthropogenic environmental change and the emergence of infectious diseases in wildlife. Acta Trop. 2001, 78(2), 103-116.
44. Mahy, B. W.; Brown, C. C. Emerging zoonoses: crossing the species barrier. Rev. Sci. Tech. 2000, 19(1), 33-40.
45. Meslin, F. X.; Stohr, K.; Heymann, D. Public health implications of emerging zoonoses. Rev. Sci. Tech. 2000, 19(1), 310-317.
46. Daszak, P.; Cunningham, A. A.; Hyatt, A. D. Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 2000, 287(5452), 443-449.
47. Cohen, M. L. Resurgent and emergent disease in a changing world. Br. Med. Bull. 1998, 54(3), 523-532.
48. Morse, S. S. Factors in the emergence of infectious diseases. Emerging Infect. Dis. 1995, 1(1), 7-15.
49. Nichol, S. T.; Arikawa, J.; Kawaoka, Y. Emerging viral diseases. Proc. Natl. Acad. Sci. USA 2000, 97(23), 12411-12412.
50. Wilson, M. E. The traveller and emerging infections: sentinel, courier, transmitter. J. Appl. Microbiol. 2003, 94 (Suppl.), 1S-11S.
51. Rice, L. B. Emergence of vancomycin-resistant enterococci. Emerging Infect. Dis. 2001, 7(2), 183-187.
52. Mah, M. W.; Memish, Z. A. Antibiotic resistance. An impending crisis. Saudi Med. J. 2000, 21(12), 1125-1129.
53. Farmer, P. Social inequalities and emerging infectious diseases. Emerging Infect. Dis. 1996, 2, 259-269.
54. Fitch, J. P.; Raber, E.; Imbro, D. R. Technology challenges in responding to biological or chemical attacks in the civilian sector. Science 2003, 302(5649), 1350-1354.
55. Alexander, D. A. Bioterrorism: preparing for the unthinkable. J. R. Army Med. Corps 2003, 149(2), 125-130.
56. Atlas, R. M. Bioterrorism and biodefence research: changing the focus of microbiology. Nat. Rev. Microbiol. 2003, 1(1), 70-74.
57. Lane, H. C.; La Montagne, J. R.; Fauci, A. S. Bioterrorism: a clear and present danger. Nature Medicine 2001, 7(12): 1271-1273.
58. Kwik, G.; Fitzgerald, J.; Inglesby, T. V.; O'Toole, T. Biosecurity: responsible stewardship of bioscience in an age of catastrophic terrorism. Biosecur. Bioterror. 2003, 1(1), 27-35.
59. Barnaby, W. The Plague Makers: The Secret World of Biological Warfare, Vision Paperbacks, London, 1997.
60. Preston, R. The Demon in the Freezer: The Terrifying Truth About the Threat from Bioterrorism, Random House, New York, 2002.
61. Guharoy, R.; Panzik, R.; Noviasky, J. A.; Krenzelok, E. P.; Blair, D. C. Smallpox: clinical features, prevention, and management. Ann. Pharmacother. 2004, 38 (3), 440-447.
62. Crotty, S.; Felgner, P.; Davies, H.; Glidewell, J.; Villarreal, L.; Ahmed, R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 2003, 171, 4969-4973.
63. Wright, M. E.; Fauci, A. S. Smallpox immunization in the 21st century: the old and the new. JAMA 2003, 289, 3306-3308.
64. Lane, J. M.; Goldstein, J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann. Intern. Med. 2003, 138, 488-493.
65. Everett, W. W.; Coffin, S. E.; Zaoutis, T.; Halpern, S. D.; Strom, B. L. Smallpox vaccination: a national survey of emergency health care providers. Acad. Emerg. Med. 2003, 10, 606-611.
66. Booss, J.; Davis, L. E. Smallpox and smallpox vaccination: neurological implications. Neurology 2003, 60, 1241-1245.
67. Blendon, R. J.; DesRoches, C. M.; Benson, J. M.; Herrmann, M. J.; Taylor-Clark, K.; Weldon, K. J. The public and the smallpox threat. N. Engl. J. Med. 2003, 348, 426-432.
68. Neff, J. M.; Lane, J. M.; Fulginiti, V. A.; Henderson, D. A. Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA 2002, 288, 1901-1905.
69. Halloran, M. E.; Longini, I. M. Jr.; Nizam, A.; Yang, Y. Containing bioterrorist smallpox. Science 2002, 298, 1428-1432.
70. Committee on Infectious Diseases. Smallpox vaccine. Pediatrics 2002, 110, 841-845.
71. Poland, G. A.; Neff, J. M. Smallpox vaccine: problems and prospects. Immunol. Allergy Clin. North Am. 2003, 23(4): 731-743.
72. Henderson, D. A.; Inglesby, T. V.; Bartlett, J. G.; Ascher, M. S.; Eitzen, E.; Jahrling, P. B.; Hauer, J.; Layton, M.; McDade, J.; Osterholm, M. T.; O'Toole, T.; Parker, G.; Perl, T.; Russell, P. K.; Tonat, K. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999, 281(22), 2127-2137.
73. Mayr, A. Smallpox vaccination and bioterrorism with pox viruses. Comp. Immunol. Microbiol. Infect. Dis. 2003, 26(5-6), 423-430.
74. Finkel, E. Australia. Engineered mouse virus spurs bioweapon fears. Science 2001 (Jan. 26), 291(5504), 585.
75. Jackson, R. J.; Ramsay, A. J.; Christensen, C. D.; Beaton, S.; Hall, D. F.; Ramshaw, I. A. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol. 2001, 75(3), 1205-1210.
76. Committee on R&D Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents. Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response, Institute of Medicine, National Academy Press, Washington, DC, 1999.
77. Division of Health Science[s] Policy, Institute of Medicine [and] Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council. Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents Interim Report on Current Capabilities, National Academy Press, Washington, DC, 1998.
78. Ellison, D. H. Emergency Action for Chemical and Biological Warfare Agents, CRC Press, Boca Raton, FL, 1999.
79. Layne, S. P.; Beugelsdijk, T. J.; and Patel, C. K. N. eds. Firepower in the Lab: Automation in the Fight Against Infectious Diseases and Bioterrorism, JosephHenryPress, Washington.DC, 2001.
80. Miller, J.; Engelberg, S.; Broad, W. Germs: Biological Weapons and America's Secret War, Simon & Schuster, New York, 2001.
81. Osterholm, M. T.; Schwartz, J. Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe, Delacorte Press, New York, 2000.
82. Anon. How would you handle a terrorist act involving weapons of mass destruction? ED Management 1999, 11(11), 121-24.
83. Amon, S. S. et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285(8), 1059-1070.
84. Bravata, D. M. et al. Systematic review: surveillance systems for early detection of bioterrorism-related diseases. Ann. Intern. Med. 2004 (Jun 1), 140(11), 910-922 (review).
85. Buehler, J.W. et al. Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group. MMWR Recomm. Rep. 2004 (May 7), 53 (RR-5), 1-11.
86. Dennis, D. T. et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001, 285 (21), 2763-2773.
87. Franz, D. R. et al. Clinical recognition and management of patients exposed to biological warfare agents. Clin. Lab. Med. 2001, 21 (3), 435-473.
88. Henderson, D. A. et al. Smallpox as a biological weapon: medical and public health management. JAMA 1999, 281 (22), 2127-2137.
89. Inglesby, T. V. et al. Plague as a biological weapon: medical and public health management. JAMA 2000, 283 (17), 2281-2290.
90. Inglesby, T. V. et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999, 281 (18), 1735-1745.
91. Khan, A. S. et al. Precautions against biological and chemical terrorism directed at food and water supplies. Public Health Rep. 2001, 116 (1), 3-14.
92. Kortepeter, M. G. et al. Bioterrorism. J. Environ. Health 2001, 63 (6), 21-24.
93. MacIntyre, A. G. et al. Weapons of mass destruction events with contaminated casualties. Effective planning for health care facilities. JAMA 2000, 283 (2), 242-249.
94. Moser, R. Jr. et al. Preparing for expected bioterrorism attacks. Mil. Med. 2001, 166 (5), 369-374.
95. Raber, E. et al. Decontamination issues for chemical and biological warfare agents: how clean is clean enough? Int. J. Environ. Health Res. 2001, 11(2), 128-148.
96. Rotz, L. D. et al. Report summary: public health assessment of potential biological terrorism agents. Emerging Infect. Dis. 2002 (Feb.), 8(2), 225-230.
97. U.S. Department of Health & Human Services, Centers for Disease Control and Prevention. Recommendations and Reports. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 2000 (Apr. 21), 49 (RR-4), 1-14.
98. Biodefense Digital Library and Collaboratory
99. http://www.biodefenseeducation.org/
100. Center for Infectious Disease Research & Policy, University of Minnesota
101. http://www.cidrap.umn.edu/cidrap/content/bt/bioprep/index.html
102. Center for Nonproliferation Studies. Monterey Institute of International Studies
103. http://www.cns.miis.edu/research/cbw/tech.htm
104. Emerging Infectious Diseases
105. http://www.cdc.gov/ncidod/eid/index.htm
106. Federal Emergency Management Agency
107. http://www.fema.gov/hazards/terrorism/terror.shtm
108. General Services Administration. FirstGov
109. http://www.firstgov.gov/Topics/Usgresponse.shtml
110. Health Sciences Library System. University of Pittsburgh
111. http://www.hsls.pitt.edu/bioterrorism/citations.html
112. http://www.hsls.pitt.edu/guides/internet/terror
113. Henry L. Stimson Center
114. http://www.stimson.org/?SN=CB2001112953
115. Johns Hopkins University
116. http://www.hopkins-biodefense.org/
117. National Institute of Allergy and Infectious Diseases
118. http://www.niaid.nih.gov/
119. http://www.niaid.nih.gov/publications/bioterrorism.html
120. http://www2.niaid.nih.gov/biodefense/
121. National Technical Information Service
122. http://www.ntis.gov/hs/index.asp
123. Occupational Safety and Health Administration
124. http://www.osha-slc.gov/SLTC/emergencypreparedness/biologi-calsub.html
125. http://www.osha-slc.gov/SLTC/emergencypreparedness/index.html
126. Public Broadcasting System. NOVA Online
127. http://www.pbs.org/wgbh/nova/bioterror/
128. SIPRI-Stockholm International Peace Research Institute
129. http://projects.sipri.se/cbw/
130. St. Louis University. School of Public Health
131. http://www.slu.edu/colleges/sph/bioterrorism/
132. Stimson Center Report No. 35
133. http://www.stimson.org/cbw/pubs.cfm?id=12
134. U.S. Centers for Disease Control and Prevention
135. http://www.bt.cdc.gov/Agent/Agentlist.asp
136. U.S. Department of State. Fact Sheet
137. http://travel.state.gov/cbw.html
138. Vector-borne Diseases and Climate Change
139. http://www.ciesin.org/TG/HH/veclev2.html
140. Virology Websites
141. http://www.tulane.edu/%7Edmsander/garryfavwebindex.html
142. WHO: Emerging and Other Communicable Diseases
143. http://www.who.int/csr/don/en/